Oxbryta lawyers for sickle cell drug lawsuits.

Oxbryta Lawyers for Sickle Cell Injury Claims

Call Now:  (888) 510-9251

Hotline Open 24 Hours

Our Oxbryta lawyers file vaso-occlusive crisis lawsuits for sickle cell disease patients harmed by their medication.  Oxbryta lawsuits claim the manufacturers of this drug failed to warn doctors and patients of the organ failure risk.

As such, sickle cell disease patients suffering a cardiovascular or related injury after taking Oxbryta may be eligible to claim a cash settlement.

Sickle Cell Disease Drugmaker Failed to Warn of Organ Failure

Our team of Oxbryta attorneys have represented thousands of victims of dangerous pharmaceutical products.  In doing so, we have recovered millions of dollars in settlement funds on their behalf.

However, we only pursue compensation from Oxbryta manufacturers and their affiliates, and do not file claims against our clients’ doctors or hospitals.

No Legal Fee Unless You Obtain a Settlement

While compensation may be available to qualified Oxbryta claimants, victims are urged to act promptly.  The #1 claim Oxbryta victims can make for sickle cell compensation is one that is filed within the Statute of Limitations time period. Click here for the latest information on the pending multi-district litigation.

Our Oxbryta lawyers are available to review claims now.  We offer a free case evaluation to confirm the use of Oxbryta and diagnosis of a related cardiovascular injury.  Further, we never charge a legal fee unless a financial recovery is obtained for our client.

Contact our Oxbryta lawyers today.

Oxbryta Lawyers File Sickle Cell Drug Injury Lawsuits

Oxbryta (voxelotor) treats sickle cell disease (SCD). The FDA approved the drug in 2019 as a breakthrough therapy. It works by increasing hemoglobin’s ability to carry oxygen. Many patients hoped it would reduce pain crises and improve their quality of life.

However, some patients experienced severe side effects. Lawsuits now claim that Oxbryta’s manufacturer failed to warn about the risks. Lawyers argue that Global Blood Therapeutics (GBT), now owned by Pfizer, ignored safety concerns and rushed the drug to market.

Click here to view the FDA voluntary recall notice.

What Is Oxbryta?

Oxbryta treats sickle cell disease, a painful and life-threatening condition. SCD causes misshapen red blood cells that block blood flow and lead to complications. Oxbryta works by preventing red blood cells from clumping together.

• Manufacturer: Global Blood Therapeutics (GBT), acquired by Pfizer in 2022.
• Approval Date: The FDA approved Oxbryta in November 2019 under accelerated review.
• Mechanism of Action: The drug binds to hemoglobin and increases its ability to carry oxygen.
• Goal: Reduce anemia, pain episodes, and organ damage caused by SCD.

Doctors prescribed Oxbryta as an alternative to traditional sickle cell treatments. Patients expected relief. Instead, some suffered serious complications.

Why Are Patients Filing Lawsuits?

Many patients did not experience the expected benefits of Oxbryta. Some developed new or worsening health issues after starting the drug. Lawyers argue that the manufacturer misled patients and failed to disclose potential dangers.

Victims claim that GBT and Pfizer:

• Did not properly test the drug before launching it.
• Downplayed risks in their marketing materials.
• Failed to warn doctors and patients about serious side effects.
• Ignored patient complaints about complications.

These lawsuits seek compensation for medical expenses, lost wages, and pain and suffering.

Oxbryta Lawyer Links Vaso-Occlusive Crisis to Sickle Cell Drug

Many patients reported unexpected health problems after taking Oxbryta. Some required emergency medical treatment.

1. Liver Damage (Hepatotoxicity)

• Some patients experienced high liver enzyme levels after starting Oxbryta.
• Others developed jaundice (yellowing of the skin and eyes).
• Severe cases led to liver failure and hospitalization.

2. Worsening Anemia

• Instead of improving anemia, Oxbryta lowered hemoglobin levels in some patients.
• Some patients needed blood transfusions to recover.
• Many reported increased fatigue, dizziness, and weakness.

3. Heart Problems

• Some patients experienced irregular heartbeats (arrhythmias).
• Reports linked Oxbryta to high blood pressure and chest pain.
• These symptoms increased the risk of heart failure.

4. Severe Headaches and Dizziness

• Many patients suffered from constant migraines and lightheadedness.
• Some could not work or complete daily tasks.

5. Gastrointestinal Issues

• Common complaints included nausea, vomiting, and diarrhea.
• Some patients experienced severe abdominal pain and dehydration.

These side effects raised concerns about Oxbryta’s long-term safety. Many patients stopped taking the drug after experiencing these complications.

Oxbryta Lawyers Claim Negligent Sale of Drug

Lawyers filing Oxbryta lawsuits argue that GBT and Pfizer failed to protect patients. Plaintiffs claim the company:

1. Rushed the Drug to Market

• The FDA fast-tracked Oxbryta’s approval through its accelerated program.
• GBT did not conduct long-term studies before releasing the drug.
• Lawsuits argue that patients became test subjects for an unsafe medication.

2. Misled Patients and Doctors

• GBT and Pfizer marketed Oxbryta aggressively.
• They claimed the drug reduced pain crises and organ damage.
• Many patients did not experience these benefits.

3. Failed to Warn About Serious Side Effects

• Oxbryta’s label did not fully disclose risks of liver damage, anemia, and heart problems.
• Some lawsuits argue that GBT knew about these dangers from clinical trials.
• The company continued promoting the drug without issuing proper warnings.

4. Ignored Post-Market Complaints

• Many patients reported severe reactions after taking Oxbryta.
• Lawsuits claim that GBT and Pfizer ignored or dismissed these concerns.
• The companies did not update safety guidelines despite evidence of harm.

Victims argue that these failures put lives at risk. They now seek financial compensation and stronger safety regulations.

Who Can File an Oxbryta Lawsuit?

Patients who suffered serious side effects after taking Oxbryta may qualify for legal action. Strong cases involve:

• Vaso-occlusive crisis
• Liver damage or liver failure after using the drug.
• Worsening anemia requiring blood transfusions.
• Severe heart problems, including arrhythmias and high blood pressure.
• Hospitalization due to side effects.
• Long-term health issues caused by Oxbryta.

A qualified medical injury lawyer can review cases and determine eligibility.

Potential Compensation for Victims

Lawsuits against GBT and Pfizer seek financial compensation for affected patients. Possible damages include:

• Medical costs for hospital stays, doctor visits, and treatments.
• Lost wages for time off work due to side effects.
• Pain and suffering for physical and emotional distress.
• Punitive damages if the court finds the company acted recklessly.

Compensation can help victims recover financially and access better healthcare.

How an Oxbryta Attorney Can Help

Hiring an experienced drug injury lawyer increases the chances of a successful case. Attorneys can:

• Investigate Oxbryta’s safety data and clinical trial records.
• Gather medical records to prove harm caused by the drug.
• Negotiate settlements with Pfizer and insurance companies.
• Take the case to trial if necessary.

Patients should not fight alone. A skilled lawyer can guide them through the evolving process.

• More lawsuits are expected as patients report complications.
• Legal experts call for stronger FDA oversight on sickle cell drugs.
• Pfizer faces growing scrutiny over Oxbryta’s safety concerns.

These sickle cell lawsuits could force changes in how drug companies test and market medications.

Contact our Oxbryta lawyers today.

Oxbryta lawsuits highlight the risks of rushed drug approvals. Many patients trusted the drug to improve their lives. Instead, some suffered severe side effects and new health problems.

Lawyers are fighting to hold GBT and Pfizer accountable. Victims deserve justice, compensation, and better drug safety standards.

If you or a loved one experienced complications after taking Oxbryta, legal help is available. Contact a sickle cell drug injury lawyer today. These lawsuits could help prevent future harm and protect patient rights.